Skip to main content

Advertisement

Log in

Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients

  • Original Article
  • Published:
Techniques in Coloproctology Aims and scope Submit manuscript

Abstract

Background

In patients with colorectal cancer, involvement of the lymph nodes is one of the most important prognostic factors. The aim of this study was to determine the independent prognostic value of the lymph node ratio (LNR), that is the relationship between the involved and examined lymph nodes, in patients with colorectal cancer.

Methods

Included in the study were 113 patients with colorectal adenocarcinoma. The patients were divided into three groups according to the proportion of involved lymph nodes: LNR-0, when there was no lymph node involvement; LNR-1, when there was involvement of up to 20% of the examined lymph nodes, and LNR-2, when there was involvement of 21% or more of the examined nodes. The relationship between lymph node ratio, the number of lymph nodes removed, and the number of lymph nodes involved by cancer was determined. The 5-year survival was evaluated using the Kaplan-Meier test.

Results

There was a significant difference in 5-year overall between patients in the different LNR groups (p=0.009). Patients in the LNR-0 group had a 5-year overall survival greater than 80%, while those in the LNR-1 and LNR-2 groups had 5-year overall survival rates less than 60% and 40%, respectively. Multivariate analysis demonstrated that the LNR is an independent prognostic variable in 5-year overall survival (p=0.009).

Conclusion

The results showed that the LNR can be considered an independent prognostic variable in overall survival of patients with colorectal cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Surveillance Epidemiology and End Results (2009) SEER Stat Fact Sheets. Cancer: Colon and Rectum. National Cancer Institute, Rockville, MD http://seer.cancer.gov/statfacts/html/colorect.html. Accessed 19 Apr 2009

    Google Scholar 

  2. Sanfelippo PM, Beahrs OH (1972) Factors in the prognosis of adenocarcinoma of the colon and rectum. Arch Surg 104:401–406

    PubMed  CAS  Google Scholar 

  3. Cain AS, Longino LA (1970) Carcinoma of the colon in children. J Pediatr Surg 5:527–532

    Article  PubMed  CAS  Google Scholar 

  4. Wolmark N, Wieand HS, Rockette HE et al (1983) The prognostic significance of tumor location and bowel obstruction in Dukes B and C colorectal cancer. Findings from the NSABP clinical trials. Ann Surg 198:743–752

    Article  PubMed  CAS  Google Scholar 

  5. Grinnel RS (1939) The grading and prognosis of carcinoma of the colon and rectum. Ann Surg 109:500–533

    Article  Google Scholar 

  6. Dukes CE (1932) The classification of cancer of the rectum. J Pathol 35:323–332

    Article  Google Scholar 

  7. Astler VB, Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139:846–851

    Article  PubMed  CAS  Google Scholar 

  8. Dukes CE, Bussey HJR (1958) The spread of rectal cancer and its effect on prognosis. Br J Cancer 12:309–320

    PubMed  CAS  Google Scholar 

  9. Halvorsen TB, Seim E (1988) Influence of mucinous components on survival in colorectal adenocarcinomas: a multivariate analysis. J Clin Pathol 41:1068–1072

    Article  PubMed  CAS  Google Scholar 

  10. Martinez CAR, Priolli DG, Cardinalli IA et al (2006) Correlação entre o padrão de distribuição tecidual e os valores séricos do antígeno carcinoembrionário em doentes com câncer. Rev Bras Coloproct 26:41–53

    Google Scholar 

  11. Cutait R (1991) Contribuição ao estudo do antígeno carcinoembrionário e dos antígenos de superfície ABH no câncer colo-retal. Tese (Livre Docência) — Faculdade de Medicina da Universidade de São Paulo, São Paulo, pp 96

    Google Scholar 

  12. Khankhanian N, Mavligit GM, Russell WO et al (1977) Prognostic significance of vascular invasion in colorectal cancer of Dukes’ B class. Cancer 39:1195–1200

    Article  PubMed  CAS  Google Scholar 

  13. Cruz JV, Cutait R, Martinez CAR et al (2006) Importância prognostica da invasão neural no câncer colorretal. Estudo imunoistoquímico com a proteína S-10100. Rev Bras Coloproct 26:280–293

    Google Scholar 

  14. Wang Y, Jatkoe T, Zhang Y et al (2004) Gene expression profiles and molecular markers to predict recurrence of Dukes’ B colon cancer. J Clin Oncol 22:1564–1571

    Article  PubMed  CAS  Google Scholar 

  15. Sigurdson ER (2003) Lymph node dissection: is it diagnostic or therapeutic? J Clin Oncol 21:965–967

    Article  PubMed  Google Scholar 

  16. Gajra A, Newman N, Gamble GP et al (2003) Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol 21:1029–1034

    Article  PubMed  Google Scholar 

  17. Wong JH, Severino R, Honnebier MB (1999) Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol 17:2896–2900

    PubMed  CAS  Google Scholar 

  18. Le Voyer TE, Sigurdson ER, Hanlon AL et al (2003) Colon cancer survival is associated with increasing number of lymph nodes analysed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 21:2912–2919

    Article  PubMed  Google Scholar 

  19. Celen O, Yildirim E, Berberoglu U (2007) Prognostic impact of positive lymph node ratio in gastric carcinoma. J Surg Oncol 96:95–101

    Article  PubMed  Google Scholar 

  20. Persiani R, Rausei S, Biondi A et al (2008) Ratio of metastatic lymph nodes: impact on staging and survival of gastric cancer. Eur J Surg Oncol 34:519–524

    PubMed  CAS  Google Scholar 

  21. Herr HW, Bochner BH, Dalbagni G et al (2002) Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 167:1295–1298

    Article  PubMed  Google Scholar 

  22. Weir L, Speers C, D’yachkova Y et al (2002) Prognostic significance of the number of axillary lymph nodes removed in patients with node negative breast cancer. J Clin Oncol 20:1793–1799

    Article  PubMed  CAS  Google Scholar 

  23. Berger AC, Watson JC, Ross EA et al (2004) The metastatic/examined lymph node ratio is an important prognostic factor after pancreaticoduodenectomy for pancreatic adenocarcinoma. Am Surg 70:235–240

    PubMed  Google Scholar 

  24. Lee HY, Choi HJ, Park KJ et al (2007) Prognostic significance of metastatic lymph node ratio in node-positive colon carcinoma. Ann Surg Oncol 14:1712–1717

    Article  PubMed  Google Scholar 

  25. Berger AC, Sigurdson ER, LeVoyer T et al (2005) Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23:8706–8712

    Article  PubMed  Google Scholar 

  26. Wang J, Hassett JM, Dayton MT et al (2008) Lymph node ratio: role in the staging of node-positive colon cancer. Ann Surg Oncol 15:1600–1608

    Article  PubMed  Google Scholar 

  27. Derwinger K, Carlsson G, Gustavsson B (2008) A study of lymph node ratio as a prognostic marker in colon cancer. Eur J Surg Oncol 34:771–775

    PubMed  CAS  Google Scholar 

  28. Trufelli DC, Miranda Vda C, Palos CC et al (2007) Positive/total dissected lymph nodes ratio as a prognostic factor in colorectal cancer. Rev Assoc Med Bras 53:539–542

    Article  PubMed  Google Scholar 

  29. Schumacher P, Dineen S, Barnett C Jr et al (2007) The metastatic lymph node ratio predicts survival in colorectal cancer. Am J Surg 194:827–831

    Article  PubMed  Google Scholar 

  30. Nelson H, Petrelli N, Carlin A et al; National Cancer Institute Expert Panel (2001) Guideline 2000 for colon and rectal cancer surgery. J Natl Cancer Inst 93:583–596

    Article  PubMed  CAS  Google Scholar 

  31. Bando E, Yonemura Y, Taniguchi K et al (2002) Outcome of ratio of lymph node metastasis in gastric carcinoma. Ann Surg Oncol 9:775–784

    Article  PubMed  Google Scholar 

  32. American Joint Committee on Cancer (2007) Collaborative staging and coding manual. American Joint Committee on Cancer, Chicago, IL http://cancerstaging.org/cstage/manuals.html. Accessed 19 Apr 2009

    Google Scholar 

  33. Goldstein NS, Sanford W, Coffey M et al (1996) Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 106:209–216

    PubMed  CAS  Google Scholar 

  34. Chen SL, Bilchik AJ (2006) More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg 244:602–610

    PubMed  Google Scholar 

  35. Mönig SP, Baldus SE, Zirbes TK et al (1999) Lymph node size and metastatic infiltration in colon cancer. Ann Surg Oncol 6:579–581

    Article  PubMed  Google Scholar 

  36. Wood TF, Saha S, Morton DL et al (2001) Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo, and laparoscopic techniques. Ann Surg Oncol 8:150–157

    Article  PubMed  CAS  Google Scholar 

  37. Hermanek P, Giedl J, Dworak O (1989) Two programs for examination of regional lymph nodes in colorectal carcinoma with regard to the new pN classification. Pathol Res Pract 185:867–873

    PubMed  CAS  Google Scholar 

  38. Wong SL, Ji H, Hollenbeck BK et al (2007) Hospital lymph node examination rates and survival after resection for colon cancer. JAMA 298:2149–2154

    Article  PubMed  CAS  Google Scholar 

  39. Schrag D, Panageas KS, Riedel E et al (2003) Surgeon volume compared to hospital volume as a predictor of outcome following primary colon cancer resection. J Surg Oncol 83:68–78

    Article  PubMed  Google Scholar 

  40. Meyerhardt JA, Catalano PJ, Schrag D et al (2003) Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence. Ann Intern Med 139:649–657

    PubMed  Google Scholar 

  41. Herrera-Ornelas L, Justiniano J, Castillo N et al (1987) Metastases in small nodes from colon cancer. Arch Surg 122:1253–1256

    PubMed  CAS  Google Scholar 

  42. Haboubi NY, Clark P, Kaftan SM et al (1992) The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma. J R Soc Med 85:386–388

    PubMed  CAS  Google Scholar 

  43. Palma RT, Waisberg J, Bromberg S et al (2003) Micrometastasis in regional lymph nodes of extirpated colorectal carcinoma: immunohistochemical study using anti-cytokeratin antibodies AE1/AE3. Colorectal Dis 5:164–168

    Article  PubMed  CAS  Google Scholar 

  44. Messerini L, Cianchi F, Cortesini C et al (2006) Incidence and prognostic significance of occult tumor cells in lymph nodes from patients with stage IIA colorectal carcinoma. Hum Pathol 37:1259–1267

    Article  PubMed  Google Scholar 

  45. Feinstein AR, Sosin DM, Wells CK (1985) The Will Rogers phenomenon: stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 312:1604–1608

    PubMed  CAS  Google Scholar 

  46. Inoue K, Nakane Y, Iiyama H et al (2002) The superiority of ratio-based lymph node staging in gastric carcinoma. Ann Surg Oncol 9:27–34

    Article  PubMed  Google Scholar 

  47. Mammen JM, James LE, Molloy M et al (2007) The relationship of lymph node dissection and colon cancer survival in the Veterans Affairs Central Cancer Registry. Am J Surg 194:349–354

    Article  PubMed  Google Scholar 

  48. Ding YB, Chen GY, Xia JG et al (2004) Correlation of tumor-positive ratio and number of perigastric lymph nodes with prognosis of patients with surgically-removed gastric carcinoma. World J Gastroenterol 10:182–185

    PubMed  Google Scholar 

  49. Bui L, Rempel E, Reeson D et al (2006) Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study. J Surg Oncol 93:439–445

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. A. Real Martinez.

Additional information

This work was performed within the Postgraduate Program in Healthy Science, São Francisco University Medical School, Bragança Paulista, São Paulo, Brazil.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Priolli, D.G., Cardinalli, I.A., Pereira, J.A. et al. Metastatic lymph node ratio as an independent prognostic variable in colorectal cancer: study of 113 patients. Tech Coloproctol 13, 113–121 (2009). https://doi.org/10.1007/s10151-009-0467-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10151-009-0467-5

Key words

Navigation